
Delivering type I interferon to dendritic cells empowers tumor eradication and immune combination treatments
- Author
- Anje Cauwels (UGent) , Sandra Van Lint (UGent) , Franciane Paul, Genevieve Garcin, Stefaan De Koker (UGent) , Alexander Van Parys (UGent) , Thomas Wüest (UGent) , Sarah Gerlo (UGent) , José Van Der Heyden (UGent) , Yan Bordat, Dominiek Catteeuw (UGent) , Elke Rogge (UGent) , Annick Verhee (UGent) , Bart Vandekerckhove (UGent) , Nico Kley, Gilles Uzé and Jan Tavernier (UGent)
- Organization
- Keywords
- CHECKPOINT BLOCKADE, CANCER-THERAPY, PD-1 BLOCKADE, IMMUNOGENIC TUMORS, CLINICAL USE, T-CELLS, IMMUNOTHERAPY, TOXICITIES, MELANOMA, EFFICACY
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 1.22 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8550247
- MLA
- Cauwels, Anje, et al. “Delivering Type I Interferon to Dendritic Cells Empowers Tumor Eradication and Immune Combination Treatments.” CANCER RESEARCH, vol. 78, no. 2, 2018, pp. 463–74, doi:10.1158/0008-5472.CAN-17-1980.
- APA
- Cauwels, A., Van Lint, S., Paul, F., Garcin, G., De Koker, S., Van Parys, A., … Tavernier, J. (2018). Delivering type I interferon to dendritic cells empowers tumor eradication and immune combination treatments. CANCER RESEARCH, 78(2), 463–474. https://doi.org/10.1158/0008-5472.CAN-17-1980
- Chicago author-date
- Cauwels, Anje, Sandra Van Lint, Franciane Paul, Genevieve Garcin, Stefaan De Koker, Alexander Van Parys, Thomas Wüest, et al. 2018. “Delivering Type I Interferon to Dendritic Cells Empowers Tumor Eradication and Immune Combination Treatments.” CANCER RESEARCH 78 (2): 463–74. https://doi.org/10.1158/0008-5472.CAN-17-1980.
- Chicago author-date (all authors)
- Cauwels, Anje, Sandra Van Lint, Franciane Paul, Genevieve Garcin, Stefaan De Koker, Alexander Van Parys, Thomas Wüest, Sarah Gerlo, José Van Der Heyden, Yan Bordat, Dominiek Catteeuw, Elke Rogge, Annick Verhee, Bart Vandekerckhove, Nico Kley, Gilles Uzé, and Jan Tavernier. 2018. “Delivering Type I Interferon to Dendritic Cells Empowers Tumor Eradication and Immune Combination Treatments.” CANCER RESEARCH 78 (2): 463–474. doi:10.1158/0008-5472.CAN-17-1980.
- Vancouver
- 1.Cauwels A, Van Lint S, Paul F, Garcin G, De Koker S, Van Parys A, et al. Delivering type I interferon to dendritic cells empowers tumor eradication and immune combination treatments. CANCER RESEARCH. 2018;78(2):463–74.
- IEEE
- [1]A. Cauwels et al., “Delivering type I interferon to dendritic cells empowers tumor eradication and immune combination treatments,” CANCER RESEARCH, vol. 78, no. 2, pp. 463–474, 2018.
@article{8550247, author = {{Cauwels, Anje and Van Lint, Sandra and Paul, Franciane and Garcin, Genevieve and De Koker, Stefaan and Van Parys, Alexander and Wüest, Thomas and Gerlo, Sarah and Van Der Heyden, José and Bordat, Yan and Catteeuw, Dominiek and Rogge, Elke and Verhee, Annick and Vandekerckhove, Bart and Kley, Nico and Uzé, Gilles and Tavernier, Jan}}, issn = {{0008-5472}}, journal = {{CANCER RESEARCH}}, keywords = {{CHECKPOINT BLOCKADE,CANCER-THERAPY,PD-1 BLOCKADE,IMMUNOGENIC TUMORS,CLINICAL USE,T-CELLS,IMMUNOTHERAPY,TOXICITIES,MELANOMA,EFFICACY}}, language = {{eng}}, number = {{2}}, pages = {{463--474}}, title = {{Delivering type I interferon to dendritic cells empowers tumor eradication and immune combination treatments}}, url = {{http://doi.org/10.1158/0008-5472.CAN-17-1980}}, volume = {{78}}, year = {{2018}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: